These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 7864101)
1. Differential effects of interleukin-1 receptor antagonist in cytokine- and endotoxin-treated rats. Ling PR; Istfan NW; Colon E; Bistrian BR Am J Physiol; 1995 Feb; 268(2 Pt 1):E255-61. PubMed ID: 7864101 [TBL] [Abstract][Full Text] [Related]
2. Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats. Schotanus K; Tilders FJ; Berkenbosch F Endocrinology; 1993 Dec; 133(6):2461-8. PubMed ID: 8243265 [TBL] [Abstract][Full Text] [Related]
3. Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. Ling PR; Bistrian BR; Mendez B; Istfan NW Metabolism; 1994 Mar; 43(3):279-84. PubMed ID: 8139474 [TBL] [Abstract][Full Text] [Related]
4. Role of interleukin 1 and tumor necrosis factor on energy metabolism in rabbits. Tredget EE; Yu YM; Zhong S; Burini R; Okusawa S; Gelfand JA; Dinarello CA; Young VR; Burke JF Am J Physiol; 1988 Dec; 255(6 Pt 1):E760-8. PubMed ID: 3144180 [TBL] [Abstract][Full Text] [Related]
5. Roles of IL-1 and TNF-alpha in endotoxin-induced activation of nitric oxide synthase in cultured rat brain cells. Romero LI; Tatro JB; Field JA; Reichlin S Am J Physiol; 1996 Feb; 270(2 Pt 2):R326-32. PubMed ID: 8779862 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance. Colagiovanni DB; Shopp GM Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492 [TBL] [Abstract][Full Text] [Related]
7. Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism. Lang CH; Cooney R; Vary TC Am J Physiol; 1996 Aug; 271(2 Pt 1):E309-16. PubMed ID: 8770025 [TBL] [Abstract][Full Text] [Related]
8. Effect of IL-1 receptor antagonist and antiserum to TNF-alpha on LPS-induced plasma ACTH and corticosterone rise in rats. Ebisui O; Fukata J; Murakami N; Kobayashi H; Segawa H; Muro S; Hanaoka I; Naito Y; Masui Y; Ohmoto Y Am J Physiol; 1994 Jun; 266(6 Pt 1):E986-92. PubMed ID: 8023931 [TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-1 in endotoxin-induced lung injury in the rat. Rose CE; Juliano CA; Tracey DE; Yoshimura T; Fu SM Am J Respir Cell Mol Biol; 1994 Feb; 10(2):214-21. PubMed ID: 8110477 [TBL] [Abstract][Full Text] [Related]
10. Role of endogenous cytokines in endotoxin- and interleukin-1-induced pulmonary inflammatory response and oxygen tolerance. Tang G; White JE; Lumb PD; Lawrence DA; Tsan MF Am J Respir Cell Mol Biol; 1995 Mar; 12(3):339-44. PubMed ID: 7873200 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta mediates endotoxin- and tumor necrosis factor alpha-induced RGS16 protein expression in cultured cardiac myocytes. Patten M; Stübe S; Thoma B; Wieland T Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):360-5. PubMed ID: 14566449 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting interleukin-1 and tumor necrosis factor-alpha does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Emeis JJ; Hoekzema R; de Vos AF Blood; 1995 Jan; 85(1):115-20. PubMed ID: 7803788 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. van der Poll T; van Deventer SJ; ten Cate H; Levi M; ten Cate JW J Infect Dis; 1994 Mar; 169(3):665-7. PubMed ID: 8158047 [TBL] [Abstract][Full Text] [Related]
16. Influence of IL-1 receptor blockade on the human response to endotoxemia. Van Zee KJ; Coyle SM; Calvano SE; Oldenburg HS; Stiles DM; Pribble J; Catalano M; Moldawer LL; Lowry SF J Immunol; 1995 Feb; 154(3):1499-507. PubMed ID: 7822813 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Luheshi G; Miller AJ; Brouwer S; Dascombe MJ; Rothwell NJ; Hopkins SJ Am J Physiol; 1996 Jan; 270(1 Pt 1):E91-5. PubMed ID: 8772479 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Somm E; Cettour-Rose P; Asensio C; Charollais A; Klein M; Theander-Carrillo C; Juge-Aubry CE; Dayer JM; Nicklin MJ; Meda P; Rohner-Jeanrenaud F; Meier CA Diabetologia; 2006 Feb; 49(2):387-93. PubMed ID: 16385385 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8. Reznikov LL; Puren AJ; Fantuzzi G; Mühl H; Shapiro L; Yoon DY; Cutler DL; Dinarello CA J Interferon Cytokine Res; 1998 Oct; 18(10):897-903. PubMed ID: 9809626 [TBL] [Abstract][Full Text] [Related]
20. The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice. Swiergiel AH; Dunn AJ Brain Behav Immun; 1999 Sep; 13(3):252-65. PubMed ID: 10469526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]